Balaji Amines Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 13, 2025, 12:51 am

Market Cap	4,201 Cr.
Current Price	1,302
High / Low	2,550/1,112
Stock P/E	22.9
Book Value	546
Dividend Yield	0.85 %
ROCE	16.8 %
ROE	12.5 %
Face Value	2.00
PEG Ratio	-4.70

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Balaji Amines Ltd

Competitors of Balaji Amines Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujchem Distillers India Ltd	134 Cr.	375	541/93.8		390	0.00 %	1.38 %	2.17 %	1.00
Elantas Beck India Ltd	7,313 Cr.	9,225	14,980/8,150	54.0	1,094	0.08 %	23.0 %	17.4 %	10.0
Crestchem Ltd	61.5 Cr.	205	350/110	22.1	21.1	0.24 %	78.2 %	56.2 %	10.0
Chemiesynth (Vapi) Ltd	11.0 Cr.	35.8	34.1/0.00		37.5	0.00 %	1.00 %	3.38 %	10.0
Archit Organosys Ltd	80.2 Cr.	39.1	61.0/34.2	36.6	32.2	0.00 %	3.69 %	0.75 %	10.0
Industry Average	4,870.00 Cr	1,600.38		35.15	330.19	0.33%	15.75%	11.87%	7.41

All Competitor Stocks of Balaji Amines Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	565	780	670	628	586	471	464	381	383	414	385	347	313
Expenses	410	584	455	455	458	378	366	327	309	316	319	286	267
Operating Profit	155	196	215	173	128	93	98	54	74	98	66	61	46
OPM %	27%	25%	32%	27%	22%	20%	21%	14%	19%	24%	17%	17%	15%
Other Income	4	5	5	3	3	6	6	7	8	9	8	9	8
Interest	4	7	3	2	3	3	2	2	2	1	1	1	1
Depreciation	10	11	11	11	12	11	11	11	11	12	12	12	12
Profit before tax	145	183	205	162	115	85	90	48	70	93	62	57	41
Tax %	30%	29%	28%	27%	27%	35%	25%	24%	21%	22%	26%	27%	24%
Net Profit	102	131	148	119	84	55	68	36	56	72	46	41	31
EPS in Rs	27.64	33.55	37.95	28.57	19.31	14.63	16.27	10.71	15.24	21.00	13.36	12.65	10.24

Last Updated: February 28, 2025, 8:30 pm

Below is a detailed analysis of the quarterly data for Balaji Amines Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 313.00 Cr.. The value appears to be declining and may need further review. It has decreased from 347.00 Cr. (Sep 2024) to 313.00 Cr., marking a decrease of 34.00 Cr..
For Expenses, as of Dec 2024, the value is 267.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 286.00 Cr. (Sep 2024) to 267.00 Cr., marking a decrease of 19.00 Cr..
For Operating Profit, as of Dec 2024, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Sep 2024) to 46.00 Cr., marking a decrease of 15.00 Cr..
For OPM %, as of Dec 2024, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Sep 2024) to 15.00%, marking a decrease of 2.00%.
For Other Income, as of Dec 2024, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to 8.00 Cr., marking a decrease of 1.00 Cr..
For Interest, as of Dec 2024, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 12.00 Cr..
For Profit before tax, as of Dec 2024, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Sep 2024) to 41.00 Cr., marking a decrease of 16.00 Cr..
For Tax %, as of Dec 2024, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2024) to 24.00%, marking a decrease of 3.00%.
For Net Profit, as of Dec 2024, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Sep 2024) to 31.00 Cr., marking a decrease of 10.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 10.24. The value appears to be declining and may need further review. It has decreased from 12.65 (Sep 2024) to 10.24, marking a decrease of 2.41.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:08 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	509	608	616	640	668	858	940	935	1,308	2,314	2,346	1,634	1,458
Expenses	429	517	515	514	519	676	747	754	935	1,691	1,736	1,310	1,188
Operating Profit	80	91	102	127	149	182	193	181	373	623	609	324	270
OPM %	16%	15%	17%	20%	22%	21%	21%	19%	29%	27%	26%	20%	19%
Other Income	4	3	4	3	9	12	4	5	6	15	15	30	34
Interest	25	32	35	22	13	9	13	23	18	17	12	6	4
Depreciation	13	16	20	19	20	19	20	32	34	42	46	45	48
Profit before tax	46	46	51	88	126	166	165	131	327	578	567	302	252
Tax %	32%	27%	35%	34%	34%	32%	29%	26%	25%	28%	28%	23%
Net Profit	31	34	33	58	82	113	117	97	243	418	406	232	191
EPS in Rs	9.62	10.34	10.25	17.78	25.42	34.93	36.27	32.34	73.51	113.71	100.47	63.22	57.25
Dividend Payout %	14%	10%	12%	11%	9%	7%	8%	10%	5%	5%	10%	17%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	9.68%	-2.94%	75.76%	41.38%	37.80%	3.54%	-17.09%	150.52%	72.02%	-2.87%	-42.86%
Change in YoY Net Profit Growth (%)	0.00%	-12.62%	78.70%	-34.38%	-3.57%	-34.27%	-20.63%	167.61%	-78.50%	-74.89%	-39.99%

Balaji Amines Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	10%
5 Years:	12%
3 Years:	8%
TTM:	-14%

Compounded Profit Growth
10 Years:	20%
5 Years:	12%
3 Years:	-5%
TTM:	0%

Stock Price CAGR
10 Years:	29%
5 Years:	27%
3 Years:	-24%
1 Year:	-41%

Return on Equity
10 Years:	23%
5 Years:	22%
3 Years:	22%
Last Year:	12%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 3:56 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	6	6	6	6	6	6	6	6	6	6	6	6	6
Reserves	165	195	221	274	356	461	568	652	888	1,243	1,548	1,715	1,764
Borrowings	209	262	256	173	105	152	227	260	127	101	58	20	15
Other Liabilities	139	158	139	152	168	229	244	195	289	395	351	405	368
Total Liabilities	519	620	623	605	635	848	1,046	1,113	1,310	1,745	1,963	2,146	2,153
Fixed Assets	234	325	341	341	325	316	320	573	543	681	780	896	887
CWIP	63	8	3	16	25	123	269	46	173	141	113	205	283
Investments	20	20	0	0	0	0	0	48	0	0	73	0	0
Other Assets	202	267	278	248	284	409	457	446	594	923	996	1,046	983
Total Assets	519	620	623	605	635	848	1,046	1,113	1,310	1,745	1,963	2,146	2,153

Below is a detailed analysis of the balance sheet data for Balaji Amines Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
For Reserves, as of Sep 2024, the value is ₹1,764.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,715.00 Cr. (Mar 2024) to ₹1,764.00 Cr., marking an increase of 49.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹15.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 20.00 Cr. (Mar 2024) to ₹15.00 Cr., marking a decrease of 5.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹368.00 Cr.. The value appears to be improving (decreasing). It has decreased from 405.00 Cr. (Mar 2024) to ₹368.00 Cr., marking a decrease of 37.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹2,153.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,146.00 Cr. (Mar 2024) to ₹2,153.00 Cr., marking an increase of 7.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹887.00 Cr.. The value appears to be declining and may need further review. It has decreased from 896.00 Cr. (Mar 2024) to ₹887.00 Cr., marking a decrease of 9.00 Cr..
For CWIP, as of Sep 2024, the value is ₹283.00 Cr.. The value appears strong and on an upward trend. It has increased from 205.00 Cr. (Mar 2024) to ₹283.00 Cr., marking an increase of 78.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹983.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,046.00 Cr. (Mar 2024) to ₹983.00 Cr., marking a decrease of 63.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹2,153.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,146.00 Cr. (Mar 2024) to ₹2,153.00 Cr., marking an increase of 7.00 Cr..

Notably, the Reserves (1,764.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	94	111	56	85	60	140	94	144	110	220	354	224
Cash from Investing Activity +	-86	-50	-4	-29	-10	-135	-119	-130	-62	-147	-210	-164
Cash from Financing Activity +	-10	-53	-55	-54	-55	16	21	-26	-37	-57	-81	-75
Net Cash Flow	-2	7	-3	2	-5	21	-4	-12	11	16	63	-15

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-129.00	-171.00	-154.00	-46.00	44.00	30.00	-34.00	-79.00	246.00	522.00	551.00	304.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	74	79	71	71	68	73	65	81	85	93	59	71
Inventory Days	66	87	114	80	106	70	116	77	64	66	89	116
Days Payable	42	83	48	58	55	56	60	42	44	54	18	31
Cash Conversion Cycle	99	83	136	93	119	87	120	116	104	105	129	156
Working Capital Days	75	67	95	70	78	74	89	102	91	94	94	116
ROCE %	19%	18%	18%	23%	30%	32%	24%	18%	35%	49%	36%	17%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	53.70%	53.70%	53.70%	53.70%	53.71%	53.71%	53.71%	53.71%	53.71%	53.71%	53.71%	53.71%
FIIs	3.99%	4.51%	4.55%	4.39%	4.45%	4.55%	4.52%	4.58%	4.92%	5.05%	5.27%	5.16%
DIIs	0.16%	0.18%	0.24%	0.37%	0.34%	0.18%	0.90%	1.43%	1.48%	1.59%	1.79%	1.66%
Public	42.15%	41.61%	41.51%	41.53%	41.50%	41.57%	40.88%	40.31%	39.91%	39.67%	39.23%	39.46%
No. of Shareholders	1,21,044	1,19,651	1,20,785	1,29,702	1,36,644	1,40,957	1,44,990	1,41,417	1,38,017	1,32,428	1,29,160	1,29,361

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Nippon India Nifty Smallcap 250 Index Fund	5,925	0.19	1.29	5,925	2025-04-22 17:25:41	0%
Motilal Oswal Nifty Smallcap 250 Index Fund	3,723	0.19	0.81	3,723	2025-04-22 17:25:41	0%
SBI Nifty Smallcap 250 Index Fund	2,706	0.19	0.59	2,706	2025-04-22 17:25:41	0%
ICICI Prudential Nifty Smallcap 250 Index Fund	1,468	0.19	0.32	1,468	2025-04-22 17:25:41	0%
HDFC NIFTY Smallcap 250 ETF	671	0.19	0.15	671	2025-04-22 17:25:41	0%
HDFC Nifty Smallcap 250 Index Fund	520	0.19	0.11	520	2025-04-22 17:25:41	0%
Motilal Oswal Nifty 500 Index Fund	416	0.02	0.09	416	2025-04-22 17:25:41	0%
Edelweiss Nifty Smallcap 250 Index Fund	115	0.18	0.03	115	2025-04-22 17:25:41	0%
ICICI Prudential S&P BSE 500 ETF	97	0.02	0.02	97	2025-04-22 17:25:41	0%
HDFC S&P BSE 500 ETF	5	0.02	0	5	2025-04-22 17:25:41	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	63.22	100.47	113.71	73.51	32.34
Diluted EPS (Rs.)	63.22	100.47	113.71	73.51	32.34
Cash EPS (Rs.)	85.70	139.27	141.94	85.77	39.84
Book Value[Excl.RevalReserv]/Share (Rs.)	584.32	524.11	405.81	280.83	206.28
Book Value[Incl.RevalReserv]/Share (Rs.)	584.32	524.11	405.81	280.83	206.28
Revenue From Operations / Share (Rs.)	506.62	726.95	716.14	404.76	288.81
PBDIT / Share (Rs.)	109.06	192.70	196.72	117.06	57.33
PBIT / Share (Rs.)	95.06	178.63	183.76	106.44	47.57
PBT / Share (Rs.)	93.07	174.94	178.48	100.80	40.46
Net Profit / Share (Rs.)	71.70	125.21	128.98	75.15	30.08
NP After MI And SOA / Share (Rs.)	63.22	100.47	113.71	73.51	32.34
PBDIT Margin (%)	21.52	26.50	27.46	28.92	19.85
PBIT Margin (%)	18.76	24.57	25.65	26.29	16.47
PBT Margin (%)	18.37	24.06	24.92	24.90	14.01
Net Profit Margin (%)	14.15	17.22	18.01	18.56	10.41
NP After MI And SOA Margin (%)	12.47	13.82	15.87	18.16	11.19
Return on Networth / Equity (%)	11.89	20.94	29.47	26.63	15.92
Return on Capital Employeed (%)	15.41	31.91	40.87	32.30	18.16
Return On Assets (%)	9.54	16.58	19.65	18.17	9.41
Long Term Debt / Equity (X)	0.01	0.01	0.04	0.09	0.18
Total Debt / Equity (X)	0.01	0.03	0.05	0.11	0.36
Asset Turnover Ratio (%)	0.79	1.23	1.27	1.02	0.85
Current Ratio (X)	6.70	6.92	2.49	2.38	1.74
Quick Ratio (X)	4.78	4.89	1.96	1.92	1.33
Inventory Turnover Ratio (X)	3.11	4.80	7.20	5.98	3.76
Dividend Payout Ratio (NP) (%)	15.81	5.97	3.51	0.81	8.03
Dividend Payout Ratio (CP) (%)	12.94	5.23	3.15	0.71	6.17
Earning Retention Ratio (%)	84.19	94.03	96.49	99.19	91.97
Cash Earning Retention Ratio (%)	87.06	94.77	96.85	99.29	93.83
Interest Coverage Ratio (X)	54.85	52.15	37.27	20.74	8.06
Interest Coverage Ratio (Post Tax) (X)	37.06	34.89	25.44	14.31	5.23
Enterprise Value (Cr.)	6473.73	6259.55	9490.08	5807.49	1055.90
EV / Net Operating Revenue (X)	3.94	2.66	4.09	4.43	1.13
EV / EBITDA (X)	18.32	10.03	14.89	15.31	5.68
MarketCap / Net Operating Revenue (X)	4.03	2.67	4.05	4.36	0.86
Retention Ratios (%)	84.18	94.02	96.48	99.18	91.96
Price / BV (X)	3.85	4.05	7.52	6.39	1.24
Price / Net Operating Revenue (X)	4.03	2.67	4.05	4.36	0.86
EarningsYield	0.03	0.05	0.03	0.04	0.12

After reviewing the key financial ratios for Balaji Amines Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 63.22. This value is within the healthy range. It has decreased from 100.47 (Mar 23) to 63.22, marking a decrease of 37.25.
For Diluted EPS (Rs.), as of Mar 24, the value is 63.22. This value is within the healthy range. It has decreased from 100.47 (Mar 23) to 63.22, marking a decrease of 37.25.
For Cash EPS (Rs.), as of Mar 24, the value is 85.70. This value is within the healthy range. It has decreased from 139.27 (Mar 23) to 85.70, marking a decrease of 53.57.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 584.32. It has increased from 524.11 (Mar 23) to 584.32, marking an increase of 60.21.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 584.32. It has increased from 524.11 (Mar 23) to 584.32, marking an increase of 60.21.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 506.62. It has decreased from 726.95 (Mar 23) to 506.62, marking a decrease of 220.33.
For PBDIT / Share (Rs.), as of Mar 24, the value is 109.06. This value is within the healthy range. It has decreased from 192.70 (Mar 23) to 109.06, marking a decrease of 83.64.
For PBIT / Share (Rs.), as of Mar 24, the value is 95.06. This value is within the healthy range. It has decreased from 178.63 (Mar 23) to 95.06, marking a decrease of 83.57.
For PBT / Share (Rs.), as of Mar 24, the value is 93.07. This value is within the healthy range. It has decreased from 174.94 (Mar 23) to 93.07, marking a decrease of 81.87.
For Net Profit / Share (Rs.), as of Mar 24, the value is 71.70. This value is within the healthy range. It has decreased from 125.21 (Mar 23) to 71.70, marking a decrease of 53.51.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 63.22. This value is within the healthy range. It has decreased from 100.47 (Mar 23) to 63.22, marking a decrease of 37.25.
For PBDIT Margin (%), as of Mar 24, the value is 21.52. This value is within the healthy range. It has decreased from 26.50 (Mar 23) to 21.52, marking a decrease of 4.98.
For PBIT Margin (%), as of Mar 24, the value is 18.76. This value is within the healthy range. It has decreased from 24.57 (Mar 23) to 18.76, marking a decrease of 5.81.
For PBT Margin (%), as of Mar 24, the value is 18.37. This value is within the healthy range. It has decreased from 24.06 (Mar 23) to 18.37, marking a decrease of 5.69.
For Net Profit Margin (%), as of Mar 24, the value is 14.15. This value exceeds the healthy maximum of 10. It has decreased from 17.22 (Mar 23) to 14.15, marking a decrease of 3.07.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.47. This value is within the healthy range. It has decreased from 13.82 (Mar 23) to 12.47, marking a decrease of 1.35.
For Return on Networth / Equity (%), as of Mar 24, the value is 11.89. This value is below the healthy minimum of 15. It has decreased from 20.94 (Mar 23) to 11.89, marking a decrease of 9.05.
For Return on Capital Employeed (%), as of Mar 24, the value is 15.41. This value is within the healthy range. It has decreased from 31.91 (Mar 23) to 15.41, marking a decrease of 16.50.
For Return On Assets (%), as of Mar 24, the value is 9.54. This value is within the healthy range. It has decreased from 16.58 (Mar 23) to 9.54, marking a decrease of 7.04.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.03 (Mar 23) to 0.01, marking a decrease of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.79. It has decreased from 1.23 (Mar 23) to 0.79, marking a decrease of 0.44.
For Current Ratio (X), as of Mar 24, the value is 6.70. This value exceeds the healthy maximum of 3. It has decreased from 6.92 (Mar 23) to 6.70, marking a decrease of 0.22.
For Quick Ratio (X), as of Mar 24, the value is 4.78. This value exceeds the healthy maximum of 2. It has decreased from 4.89 (Mar 23) to 4.78, marking a decrease of 0.11.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.11. This value is below the healthy minimum of 4. It has decreased from 4.80 (Mar 23) to 3.11, marking a decrease of 1.69.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 15.81. This value is below the healthy minimum of 20. It has increased from 5.97 (Mar 23) to 15.81, marking an increase of 9.84.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 12.94. This value is below the healthy minimum of 20. It has increased from 5.23 (Mar 23) to 12.94, marking an increase of 7.71.
For Earning Retention Ratio (%), as of Mar 24, the value is 84.19. This value exceeds the healthy maximum of 70. It has decreased from 94.03 (Mar 23) to 84.19, marking a decrease of 9.84.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 87.06. This value exceeds the healthy maximum of 70. It has decreased from 94.77 (Mar 23) to 87.06, marking a decrease of 7.71.
For Interest Coverage Ratio (X), as of Mar 24, the value is 54.85. This value is within the healthy range. It has increased from 52.15 (Mar 23) to 54.85, marking an increase of 2.70.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 37.06. This value is within the healthy range. It has increased from 34.89 (Mar 23) to 37.06, marking an increase of 2.17.
For Enterprise Value (Cr.), as of Mar 24, the value is 6,473.73. It has increased from 6,259.55 (Mar 23) to 6,473.73, marking an increase of 214.18.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.94. This value exceeds the healthy maximum of 3. It has increased from 2.66 (Mar 23) to 3.94, marking an increase of 1.28.
For EV / EBITDA (X), as of Mar 24, the value is 18.32. This value exceeds the healthy maximum of 15. It has increased from 10.03 (Mar 23) to 18.32, marking an increase of 8.29.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.03. This value exceeds the healthy maximum of 3. It has increased from 2.67 (Mar 23) to 4.03, marking an increase of 1.36.
For Retention Ratios (%), as of Mar 24, the value is 84.18. This value exceeds the healthy maximum of 70. It has decreased from 94.02 (Mar 23) to 84.18, marking a decrease of 9.84.
For Price / BV (X), as of Mar 24, the value is 3.85. This value exceeds the healthy maximum of 3. It has decreased from 4.05 (Mar 23) to 3.85, marking a decrease of 0.20.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.03. This value exceeds the healthy maximum of 3. It has increased from 2.67 (Mar 23) to 4.03, marking an increase of 1.36.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.03, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Balaji Amines Ltd as of May 12, 2025 is: 1,260.97

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 12, 2025, Balaji Amines Ltd is Overvalued by 3.15% compared to the current share price 1,302.00

Intrinsic Value of Balaji Amines Ltd as of May 12, 2025 is: 1,199.47

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 12, 2025, Balaji Amines Ltd is Overvalued by 7.87% compared to the current share price 1,302.00

Last 5 Year EPS CAGR: -4.88%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 26.58%, which is a positive sign. The company has higher reserves (773.08 cr) compared to borrowings (151.15 cr), indicating strong financial stability. The company has shown consistent growth in sales (444.69 cr) and profit (218.85 cr) over the years.	The stock has a high average Working Capital Days of 87.08, which may not be favorable. The stock has a high average Cash Conversion Cycle of 112.25, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balaji Amines Ltd:
1. Net Profit Margin: 14.15%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 15.41% (Industry Average ROCE: 15.75%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 11.89% (Industry Average ROE: 11.87%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 37.06
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 4.78
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 22.9 (Industry average Stock P/E: 26.88)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.01
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Balaji Amines Ltd. is a Public Limited Listed company incorporated on 27/10/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24132MH1988PLC049387 and registration number is 049387. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 1337.84 Cr. and Equity Capital is Rs. 6.48 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Others	Balaji Towers, No. 9/1/A/1, Solapur Maharashtra 413224	cs@balajiamines.com http://www.balajiamines.com

Management
Name	Position Held
Mr. A Prathap Reddy	Executive Chairman
Mr. D Ram Reddy	Managing Director
Mr. A Srinivas Reddy	WholeTime Director & CFO
Mr. N Rajeshwar Reddy	Whole Time Director
Mr. Mohan Kumar Ramakrishna	Independent Director
Mr. Adabala Seshagiri Rao	Independent Director
Dr. Suhasini Yatin Shah	Independent Director
Dr. Uma Rajiv Pradhan	Independent Director

FAQ

What is the intrinsic value of Balaji Amines Ltd?

Balaji Amines Ltd's intrinsic value (as of 12 May 2025) is ₹1260.97 — 3.15% lower the current market price of 1,302.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,201 Cr. market cap, FY2025-2026 high/low of ₹2,550/1,112, reserves of 1,764 Cr, and liabilities of 2,153 Cr.

What is the Market Cap of Balaji Amines Ltd?

The Market Cap of Balaji Amines Ltd is 4,201 Cr..

What is the current Stock Price of Balaji Amines Ltd as on 12 May 2025?

The current stock price of Balaji Amines Ltd as on 12 May 2025 is 1,302.

What is the High / Low of Balaji Amines Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Balaji Amines Ltd stocks is ₹2,550/1,112.

What is the Stock P/E of Balaji Amines Ltd?

The Stock P/E of Balaji Amines Ltd is 22.9.

What is the Book Value of Balaji Amines Ltd?

The Book Value of Balaji Amines Ltd is 546.

What is the Dividend Yield of Balaji Amines Ltd?

The Dividend Yield of Balaji Amines Ltd is 0.85 %.

What is the ROCE of Balaji Amines Ltd?

The ROCE of Balaji Amines Ltd is 16.8 %.

What is the ROE of Balaji Amines Ltd?

The ROE of Balaji Amines Ltd is 12.5 %.

What is the Face Value of Balaji Amines Ltd?

The Face Value of Balaji Amines Ltd is 2.00.